5-Fluorodeoxyuridine

去氧氟尿苷

Report date: 2024/04/26 14:20:36
NME

Base Information

Drug Name5-Fluorodeoxyuridine
Drug Alias Name脱氧氟尿苷DoxifluridinumDoxifluridineDoxifluridina枢绮 +[15] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms +[6] 
Global Approved IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms +[6] 
Approved Indications in ChinaUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms +[6] 
Original Approved Country/TerritoryJapan
Original Approved Date1987/09/03
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiyo Co LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesHangzhou Aida Pharmaceutical Co LtdNanjing Shuangke Medicine Development Co Ltd
Active IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeJ05AB
Related LinksWikipediaDrugBankKEGG